Civic Intelligence

Scientists Advancing Affordable

EIN 82-5103616 • 501(c)6 • Englewood, NJ

Profile

Scientists advancing affordable medicines, inc. (operating under the saamnow tradename) is a 501(c)(6) nonprofit trade organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. The organization will accomplish this by soliciting input from a broad group of pharmaceutical stakeholders including, but not limited to those involved in manufacturing, packaging, testing, research & development, supplying material and equipment, providing services, academia, regulatory science, and government agencies such as the fda and ema.

155 North Dean Street 5Englewood, NJ 07631

saamnow.com

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

NTEE S41 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

NTEE S41 • <$500k nonprofits • Source year 2024

Net Margin

6th percentile

-104%

Higher net margin than 6% of similar nonprofits.

NTEE S41 • <$500k nonprofits • Source year 2024

Top Officer Pay

83rd percentile

$0

Higher top officer pay than 83% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

NTEE S41 • <$500k nonprofits • Source year 2024

Asset Growth

15th percentile

-32%

Faster asset growth than 15% of similar nonprofits.

NTEE S41 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

11th percentile

-49%

Faster revenue growth than 11% of similar nonprofits.

NTEE S41 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets57th percentile

Assets

Down

$20,961

Down $9,640 (-32%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Down

$20,961

Down $9,640 (-32%) from 2023

Operations
Liabilities / Revenue56th percentileNet Margin6th percentile

Revenue

Down

$9,300

Down $8,800 (-49%) from 2023

Expenses

Up

$18,940

Up $1,552 (+8.9%) from 2023

Net Income

Down

-$9,640

Down $10,352 (-1454%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth15th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$60K$40K$20K$0Assets 2018: $55,773Liabilities 2018: $0Net Assets 2018: $55,7732018Assets 2019: $39,518Liabilities 2019: $0Net Assets 2019: $39,5182019Assets 2020: $51,126Liabilities 2020: $0Net Assets 2020: $51,1262020Assets 2021: $50,748Liabilities 2021: $0Net Assets 2021: $50,7482021Assets 2022: $29,889Liabilities 2022: $0Net Assets 2022: $29,8892022Assets 2023: $30,601Liabilities 2023: $0Net Assets 2023: $30,6012023Assets 2024: $20,961Liabilities 2024: $0Net Assets 2024: $20,9612024

Highlighted filing

2024

Assets$20,961
Liabilities$0
Net Assets$20,961
Open 2024 Filing

Operations Trend

Revenue Growth11th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$150K$100K$50K$0-$50KRevenue 2018: $136,680Expenses 2018: $80,907Net Income 2018: $55,7732018Revenue 2019: $154,850Expenses 2019: $171,105Net Income 2019: -$16,2552019Revenue 2020: $34,841Expenses 2020: $23,233Net Income 2020: $11,6082020Revenue 2021: $15,216Expenses 2021: $15,594Net Income 2021: -$3782021Revenue 2022: $8,475Expenses 2022: $29,334Net Income 2022: -$20,8592022Revenue 2023: $18,100Expenses 2023: $17,388Net Income 2023: $7122023Revenue 2024: $9,300Expenses 2024: $18,940Net Income 2024: -$9,6402024

Highlighted filing

2024

Revenue$9,300
Expenses$18,940
Net Income-$9,640
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$20,961
Liabilities
$0
Net assets
$20,961
Revenue
$9,300
Expenses
$18,940
Net income
-$9,640
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.21$0.00$0.21$0.09$0.19$0.10
2023Detailed filing. Detailed filing data is available for this year.$0.31$0.00$0.31$0.18$0.17$0.01
2022Detailed filing. Detailed filing data is available for this year.$0.30$0.00$0.30$0.08$0.29$0.21
2021Detailed filing. Detailed filing data is available for this year.$0.51$0.00$0.51$0.15$0.16$0.00
2020Detailed filing. Detailed filing data is available for this year.$0.51$0.00$0.51$0.35$0.23$0.12
2019Detailed filing. Detailed filing data is available for this year.$0.40$0.00$0.40$1.55$1.71$0.16
2018Detailed filing. Detailed filing data is available for this year.$0.56$0.00$0.56$1.37$0.81$0.56
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Nov 12, 2025
Return Version
2024v5.2
Gross Receipts
$9,300
Mission and Program Overview

Mission

Scientists advancing affordable medicines, inc. (operating under the saamnow tradename) is a 501(c)(6) nonprofit trade organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. The organization will accomplish this by soliciting input from a broad group of pharmaceutical stakeholders including, but not limited to those involved in manufacturing, packaging, testing, research & development, supplying material and equipment, providing services, academia, regulatory science, and government agencies such as the fda and ema.

Program Services

DescriptionGrantsExpenses
ANNUAL WORKSHOP THAT WILL BE OF INTEREST TO, AND ATTENDED BY, VARIOUS AFFORDABLE MEDICINE STAKEHOLDERS.$0$9,292
Compensation and Service Providers
Top Officer Pay83rd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
SUSANA ALMEIDATrustee-$0--
ANNA SCHWENDEMANTrustee-$0--
PRADEEP BHADAURIATrustee-$0--
JANET VAUGHNTrustee-$0--
KEITH GALLICANOPresident-$0--
CHARLES E DILIBERTITreasurer-$0--
JOHN CAPICCHIONISecretary-$0--
KEITH WEBBERTrustee-$0--
PINA D'ANGELOTrustee-$0--
Filing and Contact Details

Filer

Filer Name
Scientists Advancing Affordable
EIN
82-5103616
Phone
9737440160
Address
155 NORTH DEAN STREET 5, ENGLEWOOD, NJ 07631

Signing Officer

Name
Charles E Diliberti
Title
Treasurer
Phone
8778295500
Signed
2025-11-12
Discuss with paid preparer
Yes

Preparer

Firm
Malesardi Quackenbush Swift & Co LLC
Address
155 NORTH DEAN STREET - SUITE 5, ENGLEWOOD, NJ 07631
Preparer
Andy Maldonado
Phone
2015674100
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16 - Other Expenses

“Description: insurance expense. Amount: 4,635. Description: office expense. Amount: 5,013. Total to form 990-ez, line 16: 9,648.”

Raw XML Appendix140 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum09737440160
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0155 NORTH DEAN STREET 5
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0ENGLEWOOD
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NJ
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd007631
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt030601
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt020961
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt09000
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-9640
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt09292
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt030601
IRS990EZ/Form990TotalAssetsGrp/EOYAmt020961
IRS990EZ/GrossReceiptsAmt09300
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MembershipDuesAmt0300
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt030601
IRS990EZ/NetAssetsOrFundBalancesEOYAmt020961
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt030601
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt020961
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt71.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt81.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0SUSANA ALMEIDA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1ANNA SCHWENDEMAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2PRADEEP BHADAURIA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3JANET VAUGHN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4KEITH GALLICANO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5CHARLES E DILIBERTI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6JOHN CAPICCHIONI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7KEITH WEBBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm8PINA D'ANGELO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0TRUSTEE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1TRUSTEE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TRUSTEE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3TRUSTEE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6SECRETARY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7TRUSTEE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt8TRUSTEE
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501cInd0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt09648
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0SCIENTISTS ADVANCING AFFORDABLE MEDICINES, INC. (OPERATING UNDER THE SAAMNOW TRADENAME) IS A 501(C)(6) NONPROFIT TRADE ORGANIZATION THAT SEEKS TO PROVIDE A DEDICATED PLATFORM FOR SCIENTISTS TO SHARE CUTTING-EDGE RESEARCH THAT FACILITATES THE DEVELOPMENT OF HIGH-QUALITY, AFFORDABLE MEDICINES, THEREBY IMPROVING THEIR ACCESSIBILITY TO PATIENTS. THE ORGANIZATION WILL ACCOMPLISH THIS BY SOLICITING INPUT FROM A BROAD GROUP OF PHARMACEUTICAL STAKEHOLDERS INCLUDING, BUT NOT LIMITED TO THOSE INVOLVED IN MANUFACTURING, PACKAGING, TESTING, RESEARCH & DEVELOPMENT, SUPPLYING MATERIAL AND EQUIPMENT, PROVIDING SERVICES, ACADEMIA, REGULATORY SCIENCE, AND GOVERNMENT AGENCIES SUCH AS THE FDA AND EMA.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0ANNUAL WORKSHOP THAT WILL BE OF INTEREST TO, AND ATTENDED BY, VARIOUS AFFORDABLE MEDICINE STAKEHOLDERS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt09292
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NJ
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TotalExpensesAmt018940
IRS990EZ/TotalProgramServiceExpensesAmt09292
IRS990EZ/TotalRevenueAmt09300
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTPS://SAAMNOW.COM
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: INSURANCE EXPENSE. AMOUNT: 4,635. DESCRIPTION: OFFICE EXPENSE. AMOUNT: 5,013. TOTAL TO FORM 990-EZ, LINE 16: 9,648.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
TransferPrsnlBnftContractsDecl/DeclarationDesc0THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0CHARLES E DILIBERTI
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum08778295500
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-11-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0SCIENTISTS ADVANCING AFFORDABLE
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0MEDICINES INC
ReturnHeader/Filer/BusinessNameControlTxt0SCIE
ReturnHeader/Filer/EIN0825103616
ReturnHeader/Filer/PhoneNum09737440160
ReturnHeader/Filer/USAddress/AddressLine1Txt0155 NORTH DEAN STREET 5
ReturnHeader/Filer/USAddress/CityNm0ENGLEWOOD
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NJ
ReturnHeader/Filer/USAddress/ZIPCd007631
ReturnHeader/IRSResponsiblePrtyInfoCurrInd00
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0221624206
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0MALESARDI QUACKENBUSH SWIFT & CO LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0155 NORTH DEAN STREET - SUITE 5
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ENGLEWOOD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NJ
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd007631
ReturnHeader/PreparerPersonGrp/PhoneNum02015674100
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ANDY MALDONADO
ReturnHeader/ReturnTs02025-11-12T12:32:05-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.